Rainmed Medical Limited (2297) Stock Statistics & Valuation Metrics

Rainmed Medical Limited has a market cap or net worth of HKD 241.03M. The enterprise value is HKD 374.62M.

Market Cap

HKD 241.03M

Enterprise Value

HKD 374.62M

Rainmed Medical Limited has 1,401,358,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

1,401,358,800

Owned by Insiders

―

Owned by Institutions

―

Rainmed Medical Limited’s return on equity (ROE) is -0.22 and return on invested capital (ROIC) is -20.67%.

Return on Equity (ROE)

-0.22

Return on Assets (ROA)

-0.14

Return on Invested Capital (ROIC)

-20.67%

Return on Capital Employed (ROCE)

-0.22

Revenue Per Employee

92.19K

Profits Per Employee

-370.59K

Employee Count

208

Asset Turnover

0.04

Inventory Turnover

0.89

The current PE Ratio of Rainmed Medical Limited is -2.97. Rainmed Medical Limited’s PEG ratio is -0.06.

PE Ratio

-2.97

PS Ratio

8.70

PB Ratio

0.57

Price to FCF

-0.96

Price to Operating Cash Flow

-3.62

PEG Ratio

-0.06

In the last 12 months, Rainmed Medical Limited had revenue of 19.18M and earned -77.08M in profits. Earnings per share was -0.06.

Revenue

19.18M

Gross Profit

9.04M

Operating Income

-79.22M

Pretax Income

-79.44M

Net Income

-77.08M

EBITDA

-54.41M

Earnings Per Share (EPS)

-0.06

In the last 12 months, operating cash flow was -52.00M and capital expenditures -160.41M, giving a free cash flow of -212.40M billion.

Operating Cash Flow

-52.00M

Free Cash Flow

-212.40M

Free Cash Flow per Share

-0.16

Rainmed Medical Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-104.06%

Earnings Yield

-35.57%

Beta

0.39

52-Week Price Change

-39.65%

50-Day Moving Average

0.17

200-Day Moving Average

0.23

Relative Strength Index (RSI)

55.09

Average Volume (3m)

550.00K

Rainmed Medical Limited upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 31, 2026

Next Earnings Date

Apr 01, 2027

Ex-Dividend Date

―

Rainmed Medical Limited as a current ratio of 1.13, with Debt / Equity ratio of 6.94%

Current Ratio

1.13

Quick Ratio

1.07

Debt to Market Cap

0.08

Net Debt to EBITDA

-0.19

Interest Coverage Ratio

-110.03

In the past 12 months, Rainmed Medical Limited has paid -37.00K in taxes.

Income Tax

-37.00K

Effective Tax Rate

0.00

Rainmed Medical Limited EV to EBITDA ratio is -8.60, with an EV/FCF ratio of -1.78.

EV to Sales

16.12

EV to EBITDA

-8.60

EV to Free Cash Flow

-1.78

EV to Operating Cash Flow

-7.27

Rainmed Medical Limited has HKD 129.01M in cash and marketable securities with HKD 181.94M in debt, giving a net cash position of -HKD 52.92M billion.

Cash & Marketable Securities

HKD 129.01M

Total Debt

HKD 181.94M

Net Cash

-HKD 52.92M

Net Cash Per Share

-HKD 0.04

Tangible Book Value Per Share

HKD 0.23

Gross margin is 30.34%, with operating margin of -297.46%, and net profit margin of -285.29%.

Gross Margin

30.34%

Operating Margin

-297.46%

Pretax Margin

-294.95%

Net Profit Margin

-285.29%

EBITDA Margin

-187.40%

EBIT Margin

-267.24%

The average price target for Rainmed Medical Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

4.35%

EPS Growth Forecast

43.23%

Smart Score

3

AI Score

46